MyFinsight
Home
Blog
About
Back
Income Statement
MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. (INKT)
source: myfinsight.com
Comprehensive loss
-$3,130,667
(27.10%↑ Y/Y)
Net loss
-$3,128,201
(26.18%↑ Y/Y)
Foreign currency
translation gain (loss)
-$2,466
(95.66%↑ Y/Y)
Interest income, net
$72,884
(20843.68%↑ Y/Y)
Other income
(expense), net
$15,809
(108.51%↑ Y/Y)
Operating loss
-$3,216,894
(20.62%↑ Y/Y)
Research and development
$1,887,168
(2.61%↑ Y/Y)
General and
administrative
$1,329,726
(-28.09%↓ Y/Y)
Back